MT-7716, a novel selective nonpeptidergic NOP receptor agonist, effectively blocks ethanol-induced increase in GABAergic transmission in the rat central amygdala

Frontiers in Integrative Neuroscience

Volumn 8, Issue FEB, 2014, Pages

  Kallupi, Marsida ^a,b   Oleata, Christopher S ^a   Luu, George ^a   Teshima, Koji ^c   Ciccocioppo, Roberto ^b   Roberto, Marisa ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CAMERINO   (Italy)

^c MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Alcohol; Amygdala; Electrophysiology; GABA; Nociceptin; NOP receptor

Indexed keywords

EID: 84894091635     PISSN: 16625145     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnint.2014.00018     Document Type: Article

References (52)

1. Allison, S., and Sheehy, T. W. (1992). Alcohol: yesterday and today have we changed? Ala. Med. 61, 13-14, 16, 18.
2. Andreasen, M., and Hablitz, J. J. (1994). Paired-pulse facilitation in the dentate gyrus: a patch-clamp study in rat hippocampus in vitro. J. Neurophysiol. 72, 326-336.
3. Aujla, H., Cannarsa, R., Romualdi, P., Ciccocioppo, R., Martin-Fardon, R., and Weiss, F. (2013). Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal. Addict. Biol. 18, 467-479. doi: 10.1111/j.1369-1600.2012.00466.x
4. Bonci, A., and Williams, J. T. (1997). Increased probability of GABA release during withdrawal from morphine. J. Neurosci. 17, 796-803.
5. Braconi, S., Sidhpura, N., Aujla, H., Martin-Fardon, R., Weiss, F., and Ciccocioppo, R. (2010). Revisiting intragastric ethanol intubation as a dependence induction method for studies of ethanol reward and motivation in rats. Alcohol. Clin. Exp. Res. 34, 538-544. doi: 10.1111/j.1530-0277.2009.01119.x
6. Calo, G., Guerrini, R., Rizzi, A., Salvadori, S., and Regoli, D. (2000). Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129, 1261-1283. doi: 10.1038/sj.bjp.0703219
7. Ciccocioppo, R., Angeletti, S., Panocka, I., and Massi, M. (2000). Nociceptin/orphanin FQ and drugs of abuse. Peptides 21, 1071-1080. doi: 10.1016/s0196-9781(00)00245-x
8. Ciccocioppo, R., Biondini, M., Antonelli, L., Wichmann, J., Jenck, F., and Massi, M. (2002a). Reversal of stress-and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198. Psychopharmacology 161, 113-119. doi: 10.1007/s00213-002-1020-7
9. Ciccocioppo, R., De Guglielmo, G., Hansson, A. C., Ubaldi, M., Kallupi, M., Cruz, M. T., et al. (2014). Restraint stress alters Nociceptin/Orphanin FQ and CRF systems in the rat central Amygdala: significance for anxiety-like behaviors. J. Neurosci. 34, 363-372. doi: 10.1523/JNEUROSCI.2400-13.2014
10. Ciccocioppo, R., Economidou, D., Fedeli, A., Angeletti, S., Weiss, F., Heilig, M., et al. (2004). Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology 172, 170-178. doi: 10.1007/s00213-003-1645-1
11. Ciccocioppo, R., Economidou, D., Rimondini, R., Sommer, W., Massi, M., and Heilig, M. (2007). Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system. Biol. Psychiatry 61, 4-12. doi: 10.1016/j.biopsych.2006.01.006
12. Ciccocioppo, R., Panocka, I., Polidori, C., Regoli, D., and Massi, M. (1999). Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology (Berl) 141, 220-224. doi: 10.1007/s002130050828
13. Ciccocioppo, R., Polidori, C., Antonelli, L., Salvadori, S., Guerrini, R., and Massi, M. (2002b). Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats. Peptides 23, 117-125. doi: 10.1016/s0196-9781(01)00587-3
14. Cruz, M. T., Herman, M. A., Kallupi, M., and Roberto, M. (2012). Nociceptin/orphanin FQ blockade of corticotropin-releasing factor-induced gamma-aminobutyric acid release in central amygdala is enhanced after chronic ethanol exposure. Biol. Psychiatry 71, 666-676. doi: 10.1016/j.biopsych.2011.10.032
15. Dahchour, A., Lallemand, F., Ward, R. J., and De Witte, P. (2005). Production of reactive oxygen species following acute ethanol or acetaldehyde and its reduction by acamprosate in chronically alcoholized rats. Eur. J. Pharmacol. 520, 51-58. doi: 10.1016/j.ejphar.2005.07.012
16. Economidou, D., Fedeli, A., Fardon, R. M., Weiss, F., Massi, M., and Ciccocioppo, R. (2006). Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats. Peptides 27, 3299-3306. doi: 10.1016/j.peptides.2006.09.007
17. Economidou, D., Hansson, A. C., Weiss, F., Terasmaa, A., Sommer, W. H., Cippitelli, A., et al. (2008). Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. Biol. Psychiatry 64, 211-218. doi: 10.1016/j.biopsych.2008.02.004
18. Gavioli, E. C., and Calo, G. (2013). Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs. Pharmacol. Ther. 140, 10-25. doi: 10.1016/j.pharmthera.2013.05.008
19. Gilpin, N. W., Misra, K., Herman, M. A., Cruz, M. T., Koob, G. F., and Roberto, M. (2011). Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence. Biol. Psychiatry 69, 1091-1099. doi: 10.1016/j.biopsych.2011.02.004
20. Greenfield, T. K., Ye, Y., Kerr, W., Bond, J., Rehm, J., and Giesbrecht, N. (2009). Externalities from alcohol consumption in the 2005 US National Alcohol Survey: implications for policy. Int. J. Environ. Res. Public Health 6, 3205-3224. doi: 10.3390/ijerph6123205
21. Haubensak, W., Kunwar, P. S., Cai, H., Ciocchi, S., Wall, N. R., Ponnusamy, R., et al. (2010). Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 468, 270-276. doi: 10.1038/nature09553
22. Herman, M. A., Kallupi, M., Luu, G., Oleata, C. S., Heilig, M., Koob, G. F., et al. (2013). Enhanced GABAergic transmission in the central nucleus of the amygdala of genetically selected Marchigian Sardinian rats: alcohol and CRF effects. Neuropharmacology 67C, 337-348. doi: 10.1016/j.neuropharm.2012.11.026
23. Higley, A. E., Koob, G. F., and Mason, B. J. (2012). Treatment of alcohol dependence with drug antagonists of the stress response. Alcohol Res. 34, 516-521.
24. Jenck, F., Moreau, J. L., Martin, J. R., Kilpatrick, G. J., Reinscheid, R. K., Monsma, F. J., et al. (1997). Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U S A 94, 14854-14858. doi: 10.1073/pnas.94.26.14854
25. Jenck, F., Wichmann, J., Dautzenberg, F. M., Moreau, J. L., Ouagazzal, A. M., Martin, J. R., et al. (2000). A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci. U S A 97, 4938-4943. doi: 10.1073/pnas.090514397
26. Kallupi, M., Varodayan, F. P., Oleata, C. S., Correia, D., Luu, G., and Roberto, M. (2013). Nociceptin/orphanin FQ decreases glutamate transmission and blocks ethanol-induced effects in the central amygdala of naive and ethanol-dependent rats. Neuropsychopharmacology doi: 10.1038/npp.2013.308. [Epub ahead of print].
27. Koob, G. F. (2009). Brain stress systems in the amygdala and addiction. Brain Res. 1293, 61-75. doi: 10.1016/j.brainres.2009.03.038
28. Koob, G. F., and Le Moal, M. (1997). Drug abuse: hedonic homeostatic dysregulation. Science 278, 52-58. doi: 10.1126/science.278.5335.52
29. Koob, G. F., Mason, B. J., De Witte, P., Littleton, J., and Siggins, G. R. (2002). Potential neuroprotective effects of acamprosate. Alcohol. Clin. Exp. Res. 26, 586-592. doi: 10.1111/j.1530-0277.2002.tb02578.x
30. Koster, A., Montkowski, A., Schulz, S., Stube, E. M., Knaudt, K., Jenck, F., et al. (1999). Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. U S A 96, 10444-10449. doi: 10.1073/pnas.96.18.10444
31. Kuzmin, A., Kreek, M. J., Bakalkin, G., and Liljequist, S. (2007). The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking. Neuropsychopharmacology 32, 902-910. doi: 10.1038/sj.npp.1301169
32. Kuzmin, A., Sandin, J., Terenius, L., and Ogren, S. O. (2003). Acquisition, expression and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone. J. Pharmacol. Exp. Ther. 304, 310-318. doi: 10.1124/jpet.102.041350
33. Lambert, D. G. (2008). The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat. Rev. Drug Discov. 7, 694-710. doi: 10.1038/nrd2572
34. Mann, K., Kiefer, F., Spanagel, R., and Littleton, J. (2008). Acamprosate: recent findings and future research directions. Alcohol. Clin. Exp. Res. 32, 1105-1110. doi: 10.1111/j.1530-0277.2008.00690.x
35. Mann, K., Lehert, P., and Morgan, M. Y. (2004). The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol. Clin. Exp. Res. 28, 51-63. doi: 10.1097/01.alc.0000108656.81563.05
36. Martin-Fardon, R., Ciccocioppo, R., Massi, M., and Weiss, F. (2000). Nociceptin prevents stress-induced ethanol-but not cocaine-seeking behavior in rats. Neuroreport 11, 1939-1943. doi: 10.1097/00001756-200006260-00026
37. Martin-Fardon, R., Zorrilla, E. P., Ciccocioppo, R., and Weiss, F. (2010). Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: focus on corticotropin-releasing factor, nociceptin/orphanin FQ and orexin/hypocretin. Brain Res. 1314, 145-161. doi: 10.1016/j.brainres.2009.12.027
38. Meunier, J. C. (1997). Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 340, 1-15. doi: 10.1016/s0014-2999(97)01411-8
39. Meunier, J. C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., et al. (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377, 532-535. doi: 10.1038/377532a0
40. Mohapatra, S., Patra, J., Popova, S., Duhig, A., and Rehm, J. (2010). Social cost of heavy drinking and alcohol dependence in high-income countries. Int. J. Public Health 55, 149-157. doi: 10.1007/s00038-009-0108-9
41. Reinscheid, R. K., Nothacker, H. P., Bourson, A., Ardati, A., Henningsen, R. A., Bunzow, J. R., et al. (1995). Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270, 792-794. doi: 10.1126/science.270.5237.792
42. Reinscheid, R. K., Nothacker, H. P., and Civelli, O. (1999). Orphan receptors and the concept of reverse physiology: discovery of the novel neuropeptide orphanin FQ/nociceptin. Results Probl. Cell Differ. 26, 193-214. doi: 10.1007/978-3-540-49421-8_9
43. Roberto, M., Madamba, S. G., Moore, S. D., Tallent, M. K., and Siggins, G. R. (2003). Ethanol increases GABAergic transmission at both pre-and postsynaptic sites in rat central amygdala neurons. Proc. Natl. Acad. Sci. U S A 100, 2053-2058. doi: 10.1073/pnas.0437926100
44. Roberto, M., Madamba, S. G., Stouffer, D. G., Parsons, L. H., and Siggins, G. R. (2004a). Increased GABA release in the central amygdala of ethanol-dependent rats. J. Neurosci. 24, 10159-10166. doi: 10.1523/jneurosci.3004-04.2004
45. Roberto, M., Schweitzer, P., Madamba, S. G., Stouffer, D. G., Parsons, L. H., and Siggins, G. R. (2004b). Acute and chronic ethanol alter glutamatergic transmission in rat central amygdala: an in vitro and in vivo analysis. J. Neurosci. 24, 1594-1603. doi: 10.1523/jneurosci.5077-03.2004
46. Roberto, M., and Siggins, G. R. (2006). Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala. Proc. Natl. Acad. Sci. U S A 103, 9715-9720. doi: 10.1073/pnas.0601899103
47. Schank, J. R., Ryabinin, A. E., Giardino, W. J., Ciccocioppo, R., and Heilig, M. (2012). Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. Neuron 76, 192-208. doi: 10.1016/j.neuron.2012.09.026
48. Spanagel, R., and Vengeliene, V. (2013). New pharmacological treatment strategies for relapse prevention. Curr. Top. Behav. Neurosci. 13, 583-609. doi: 10.1007/7854_2012_205
49. Teshima, K., Minoguchi, M., Tounai, S., Ashimori, A., Eguchi, J., Allen, C. N., et al. (2005). Nonphotic entrainment of the circadian body temperature rhythm by the selective ORL1 receptor agonist W-212393 in rats. Br. J. Pharmacol. 146, 33-40. doi: 10.1038/sj.bjp.0706311
50. Ubaldi, M., Bifone, A., and Ciccocioppo, R. (2013). Translational approach to develop novel medications on alcohol addiction: focus on neuropeptides. Curr. Opin. Neurobiol. 23, 684-691. doi: 10.1016/j.conb.2013.04.009
51. Umhau, J. C., Schwandt, M. L., Usala, J., Geyer, C., Singley, E., George, D. T., et al. (2011). Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology 36, 1178-1186. doi: 10.1038/npp.2010.253
52. Witkin, J. M., Statnick, M. A., Rorick-Kehn, L. M., Pintar, J. E., Ansonoff, M., Chen, Y., et al. (2014). The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood and drug dependence. Pharmacol. Ther. 141, 283-299. doi: 10.1016/j.pharmthera.2013.10.011